Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Filters
Jeff Schneider
Research Professor, Robotics InstituteCarnegie Mellon University
Jeff Schneider is researching how to use machine learning to control fusion reactions.
Douglas Scharre
Professor of Clinical Neurology and Psychiatry | College of MedicineThe Ohio State University
Dr. Scharre specializes in cognitive disorders and dementias, including Alzheimer's disease
Dr Jonathan A. G. Cox
Lecturer in MicrobiologyAston University
Dr Cox's research interests surround the discovery of new antibiotics & identifying the mechanisms by which those antibiotics kill bacteria.
Pierre Baldi
Distinguished Professor of Computer Science and Director of the Artificial Intelligence in Science InstituteUC Irvine
Pierre Baldi works at the intersection of biology and computer science with an expertise in artificial intelligence and deep learning.
Andrew Lover
Associate Professor of Epidemiology and Deputy Director, New England Center of Excellence in Vector-Borne DiseaseUniversity of Massachusetts Amherst
Andrew Lover is an infectious disease epidemiologist whose work focuses on malaria and other vector-borne diseases.
Emily Walsh
Principal ConsultantHalloran Consulting Group, Inc.
Recovering Scientist
Adrian Newman-Tancredi
Neuropharmacology ConsultingNeuroAct Communication
Experienced public speaker and neuropharmacologist with proven expertise in study of antipsychotics, antidepressants and analgesics.
Jacob Elmer, PhD
Dicciani Endowed Professor of Chemical and Biological Engineering | College of EngineeringVillanova University
Jacob Elmer, PhD, is an expert in genetic engineering, GMOs and gene therapy.
Roslyn Bill
Professor of BiotechnologyAston University
Professor Bill's research on water flow in the body has revealed how to develop drugs that prevent brain swelling after injury or disease.
Avak Kahvejian
Partner, VentureLabsFlagship Pioneering
Avak Kahvejian is an expert in conceiving and launching internally generated platform companies and leveraging new biological mechanisms.